GSK plc ADR buy The Goldman Sachs Group, Inc.
Start price
27.02.23
/
50%
€33.00
Target price
27.02.24
-
Performance (%)
18.79%
End price
28.02.24
€39.20
Summary
This prediction ended on 28.02.24 with a price of €39.20. The prediction had a final performance of 18.79%. Dividends of €1.34 are taken into consideration when calculating the performance. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| GSK plc ADR | 16.972% | 16.972% | 45.714% |
| iShares Core DAX® | 1.085% | -1.655% | 13.297% |
| iShares Nasdaq 100 | -1.665% | -3.137% | 2.218% |
| iShares Nikkei 225® | 3.863% | 6.947% | 22.818% |
| iShares S&P 500 | 0.111% | -1.320% | 1.445% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread GSK plc ADR diskutieren
GSK plc (NYSE: GSK) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating on the stock.
Ratings data for GSK provided by MarketBeat
In the thread Trading GSK plc ADR
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten